Josephine Alba

Dr. Josephine Alba

University of Fribourg, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
RNRaffaele Nicastro
Raffaele Nicastro
LBLaura Brohée
Laura Brohée
JAJosephine Alba
Josephine Alba
JNJulian Nüchel
Julian Nüchel
GFGianluca Figlia
Gianluca Figlia
CDConstantinos Demetriades
Constantinos Demetriades
Cell growth is regulated by the mammalian/mechanistic target of rapamycin complex 1 (mTORC1), which functions both as a nutrient sensor and a master controller of virtually all biosynthetic pathways. This ensures that cells are metabolically active only when conditions are optimal for growth. Notably, although mTORC1 is known to regulate fatty acid biosynthesis, how and whether the cellular lipid biosynthetic capacity signals back to fine-tune mTORC1 activity remains poorly understood. Here we show that mTORC1 senses the capacity of a cell to synthesise fatty acids by detecting the levels of malonyl-CoA, an intermediate of this biosynthetic pathway. We find that, in both yeast and mammalian cells, this regulation is direct, with malonyl-CoA binding to the mTOR catalytic pocket and acting as a specific ATP-competitive inhibitor. When fatty acid synthase (FASN) is downregulated/inhibited, elevated malonyl-CoA levels are channelled to proximal mTOR molecules that form direct protein–protein interactions with acetyl-CoA carboxylase 1 (ACC1) and FASN. Our findings represent a conserved and unique homeostatic mechanism whereby impaired fatty acid biogenesis leads to reduced mTORC1 activity to coordinately link this metabolic pathway to the overall cellular biosynthetic output. Moreover, they reveal the existence of a physiological metabolite that directly inhibits the activity of a signalling kinase in mammalian cells by competing with ATP for binding.

1 September 2019 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Open access
ETElisamaria Tasca
Elisamaria Tasca
JAJosephine Alba
Josephine Alba
LGLuciano Galantini
Luciano Galantini
MDMarco D’abramo
Marco D’abramo
AGAnna Maria Giuliani
Anna Maria Giuliani
MGMauro Giustini
Mauro Giustini

10 April 2020 in Cells
Verified
Journal Article
Open access
PDF file
JAJosephine Alba
Josephine Alba
LRLorenzo Di Rienzo
Lorenzo Di Rienzo
EMEdoardo Milanetti
Edoardo Milanetti
OAOreste Acuto
Oreste Acuto
MDMarco D'Abramo
Marco D'Abramo
The major defense system against microbial pathogens in vertebrates is the adaptive immune response and represents an effective mechanism in cancer surveillance. T cells represent an essential component of this complex system. They can recognize myriads of antigens as short peptides (p) originated from the intracellular degradation of foreign proteins presented by major histocompatibility complex (MHC) proteins. The clonotypic T-cell antigen receptor (TCR) is specialized in recognizing pMHC and triggering T cells immune response. It is still unclear how TCR engagement to pMHC is translated into the intracellular signal that initiates T-cell immune response. Some work has suggested the possibility that pMHC binding induces in the TCR conformational changes transmitted to its companion CD3 subunits that govern signaling. The conformational changes would promote phosphorylation of the CD3 complex ζ chain that initiates signal propagation intracellularly. Here, we used all-atom molecular dynamics simulations (MDs) of 500 ns to analyze the conformational behavior of three TCRs (1G4, ILA1 and ILA1α1β1) interacting with the same MHC class I (HLA-A*02:01) bound to different peptides, and modelled in the presence of a lipid bilayer. Our data suggest a correlation between the conformations explored by the β-chain constant regions and the T-cell response experimentally determined. In particular, independently by the TCR type involved in the interaction, the TCR activation seems to be linked to a specific zone of the conformational space explored by the β-chain constant region. Moreover, TCR ligation restricts the conformational space the MHC class I groove.

12 February 2020 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
LRLorenzo Di Rienzo
Lorenzo Di Rienzo
EMEdoardo Milanetti
Edoardo Milanetti
JAJosephine Alba
Josephine Alba
MDMarco D’aBramo
Marco D’aBramo
In this work we describe the application of the Zernike formalism to quantitatively characterize the binding pockets of two sets of biologically relevant systems. Such an approach, when applied to molecular dynamics trajectories, is able to pinpoint the subtle differences between very similar molecular regions and their impact on the local propensity to ligand binding, allowing to quantify such differences. The statistical robustness of our procedure and the comparison with experimental data both suggest that it is very suitable to describe protein binding sites and protein-ligand interactions within a rigourous and well-defined framework.

14 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
JAJosephine Alba
Josephine Alba
MDMarco D'Abramo
Marco D'Abramo
The machinery involved in cytotoxic T-cell activation requires three main characters: the major histocompatibility complex class I (MHC I) bound to the peptide (p), the T-cell receptor (TCR), and the CD3 complex, a multidimer interfaced with the intracellular side. The pMHC:TCR interaction has been largely studied by means of both experimental and computational models, giving a contribution in understanding the complexity of the TCR triggering. Nevertheless, a detailed study of the structural and dynamical characterization of the full complex (pMHC:TCR:CD3 complex) is still missing due to a lack of structural information of the CD3-chains arrangement around the TCR. Very recently, the determination of the TCR:CD3 complex structure by means of Cryo-EM technique has given a chance to build the entire system essential in the activation of T-cells, a fundamental mechanism in the adaptive immune response. Here, we present the first complete model of the pMHC interacting with the TCR:CD3 complex, built in a lipid environment. To describe the conformational behavior associated with the unbound and the bound states, all-atom Molecular Dynamics simulations were performed for the TCR:CD3 complex and for two pMHC:TCR:CD3 complex systems, bound to two different peptides. Our data point out that a conformational change affecting the TCR Constant β (Cβ) region occurs after the binding to the pMHC, revealing a key role of this region in the propagation of the signal. Moreover, we found that TCR reduces the flexibility of the MHC I binding groove, confirming our previous results.

14 November 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
VLVictor G. Lui
Victor G. Lui
MHManfred Hoenig
Manfred Hoenig
BCBerenice Cabrera-Martinez
Berenice Cabrera-Martinez
RBRyan M. Baxter
Ryan M. Baxter
JGJosselyn E. Garcia-Perez
Josselyn E. Garcia-Perez
EHElena W.Y. Hsieh
Elena W.Y. Hsieh
Lymphocyte-specific protein tyrosine kinase (LCK) is essential for T cell antigen receptor (TCR)–mediated signal transduction. Here, we report two siblings homozygous for a novel LCK variant (c.1318C>T; P440S) characterized by T cell lymphopenia with skewed memory phenotype, infant-onset recurrent infections, failure to thrive, and protracted diarrhea. The patients’ T cells show residual TCR signal transduction and proliferation following anti-CD3/CD28 and phytohemagglutinin (PHA) stimulation. We demonstrate in mouse models that complete (Lck−/−) versus partial (LckP440S/P440S) loss-of-function LCK causes disease with differing phenotypes. While both Lck−/− and LckP440S/P440S mice exhibit arrested thymic T cell development and profound T cell lymphopenia, only LckP440S/P440S mice show residual T cell proliferation, cytokine production, and intestinal inflammation. Furthermore, the intestinal disease in the LckP440S/P440S mice is prevented by CD4+ T cell depletion or regulatory T cell transfer. These findings demonstrate that P440S LCK spares sufficient T cell function to allow the maturation of some conventional T cells but not regulatory T cells—leading to intestinal inflammation.